Introduction: Carbamazepine (CBZ) is used for the treatment of epilepsy and other
neurological and psychiatric disorders. The occurrence of adverse reactions (ADRs) to CBZ …

Objectives: Outline the toxicokinetics and pathophysiology of carbamazepine toxicity.
Identify the presentation of a patient with carbamazepine toxicity, and potential differential …

Aggregated risk of carbamazepine (CBZ)‐induced cutaneous adverse drug reactions
(cADRs) with different HLA variants are unclear and limited in terms of the power of studies …

Carbamazepine (CBZ), a dibenzazepine, is a tricyclic compound used in the treatment of
epilepsy, trigeminal neuralgia, and psychiatric mood disorders [1]. Serious adverse events …

Carbamazepine (CBZ) causes life‐threating T‐cell‐mediated hypersensitivity reactions,
including serious cutaneous adverse reactions (SCAR s) and drug‐induced liver injury (CBZ …

Most of the side effects associated with carbamazepine (Tegretol®, USP, Geigy
Pharmaceuticals) therapy are mild, transient, and reversible with an adjustment in dosage or …

Objective A considerable heterogeneity exists in the literature on the role of different HLA
alleles in carbamazepine (CBZ)-induced cutaneous adverse drug reactions (cADRs) of …

Objective To systematically review evidence on genetic risk factors for carbamazepine (CBZ)–
induced hypersensitivity reactions (HSR s) and provide practice recommendations …

Carbamazepine is one of the most commonly prescribed antiepileptic drugs and is also
used in the treatment of trigeminal neuralgia and psychiatric disorders, particularly bipolar …

The anticonvulsant carbamazepine (CBZ) frequently causes cutaneous adverse drug
reactions (cADRs), including maculopapular eruption (MPE), hypersensitivity syndrome …